Agios Pharmaceuticals, Inc. (AGIO) was a big mover last session, as the company saw its shares rise 6.4% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock has risen 23.1% since Sep 15.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Agios Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Other better-ranked med-product stocks include ICU Medical, Inc. (ICUI) and Symmetry Medical, Inc. (SMA) with a Zacks Rank #1 ( Strong Buy), along with Eagle Pharmaceuticals Inc. (EGRX) carrying a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
— Zacks Investment Research